blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2140873

EP2140873 - METHOD FOR PRODUCING AN ANTITUMORAL VACCINE BASED ON SURFACE ENDOTHELIAL CELL ANTIGENS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.07.2016
Database last updated on 03.09.2024
Most recent event   Tooltip08.12.2017Lapse of the patent in a contracting state
New state(s): LU		published on 10.01.2018  [2018/02]
Applicant(s)For all designated states
Lokhov, Petr Genrievich
Chernomorsky bulvar 23/1-45
Moscow 113452 / RU
[2010/01]
Inventor(s)01 / see applicant
...
 [2010/01]
Representative(s)V.O.
P.O. Box 87930
2508 DH Den Haag / NL
[N/P]
Former [2015/36]Hatzmann, Martin, et al
V.O.
Johan de Wittlaan 7
2517 JR Den Haag / NL
Former [2010/01]Hatzmann, Martin, et al
Vereenigde Johan de Wittlaan 7
2517 JR Den Haag / NL
Application number, filing date07852026.916.10.2007
[2010/01]
WO2007RU00570
Priority number, dateEA2007000094027.04.2007         Original published format: EA 200700940
[2010/01]
Filing languageRU
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008133546
Date:06.11.2008
Language:RU
[2008/45]
Type: A1 Application with search report 
No.:EP2140873
Date:06.01.2010
Language:EN
[2010/01]
Type: B1 Patent specification 
No.:EP2140873
Date:02.09.2015
Language:EN
[2015/36]
Search report(s)International search report - published on:RU06.11.2008
(Supplementary) European search report - dispatched on:EP06.05.2010
ClassificationIPC:A61K38/00, A61K39/00
[2010/01]
CPC:
A61P35/00 (EP,KR); A61K39/001102 (EP,KR,US); A61K35/12 (KR);
A61K39/00 (EP,US); A61K2039/515 (EP,KR,US); A61K2039/80 (EP,KR,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/36]
Former [2010/01]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINES ANTITUMORALEN IMPFSTOFFES AUF BASIS VON OBERFLÄCHEN-ENDOTHELZELL-ANTIGENEN[2010/01]
English:METHOD FOR PRODUCING AN ANTITUMORAL VACCINE BASED ON SURFACE ENDOTHELIAL CELL ANTIGENS[2010/01]
French:PROCÉDÉ DE FABRICATION D'UN VACCIN ANTITUMORAL SUR LA BASE D'ANTIGÈNES DE SURFACE DE CELLULES ENDOTHÉLIALES[2010/01]
Entry into regional phase16.09.2009Translation filed 
16.09.2009National basic fee paid 
16.09.2009Search fee paid 
16.09.2009Designation fee(s) paid 
16.09.2009Examination fee paid 
Examination procedure16.09.2009Examination requested  [2010/01]
25.11.2010Amendment by applicant (claims and/or description)
28.06.2011Despatch of a communication from the examining division (Time limit: M04)
24.10.2011Reply to a communication from the examining division
04.04.2013Despatch of a communication from the examining division (Time limit: M04)
02.08.2013Reply to a communication from the examining division
30.10.2013Despatch of a communication from the examining division (Time limit: M04)
21.02.2014Reply to a communication from the examining division
14.03.2014Despatch of a communication from the examining division (Time limit: M02)
15.05.2014Reply to a communication from the examining division
22.04.2015Communication of intention to grant the patent
24.07.2015Fee for grant paid
24.07.2015Fee for publishing/printing paid
24.07.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.06.2011
Opposition(s)03.06.2016No opposition filed within time limit [2016/32]
Fees paidRenewal fee
16.09.2009Renewal fee patent year 03
18.10.2010Renewal fee patent year 04
19.04.2012Renewal fee patent year 05
31.10.2012Renewal fee patent year 06
15.10.2013Renewal fee patent year 07
16.10.2014Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.10.201105   M06   Fee paid on   19.04.2012
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.10.2007
AT02.09.2015
BE02.09.2015
BG02.09.2015
CY02.09.2015
CZ02.09.2015
DK02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
MT02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
TR02.09.2015
LU16.10.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
[2018/02]
Former [2017/39]HU16.10.2007
AT02.09.2015
BE02.09.2015
BG02.09.2015
CY02.09.2015
CZ02.09.2015
DK02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
MT02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
TR02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2017/03]AT02.09.2015
BE02.09.2015
CZ02.09.2015
DK02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/39]AT02.09.2015
CZ02.09.2015
DK02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/36]AT02.09.2015
CZ02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SI02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/28]AT02.09.2015
CZ02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
MC02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/24]AT02.09.2015
CZ02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
PT04.01.2016
Former [2016/23]AT02.09.2015
CZ02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
NL02.09.2015
PL02.09.2015
RO02.09.2015
SE02.09.2015
SK02.09.2015
GR03.12.2015
IS02.01.2016
Former [2016/22]AT02.09.2015
CZ02.09.2015
EE02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
NL02.09.2015
PL02.09.2015
SE02.09.2015
GR03.12.2015
IS02.01.2016
Former [2016/11]AT02.09.2015
FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
SE02.09.2015
GR03.12.2015
Former [2016/10]FI02.09.2015
LT02.09.2015
LV02.09.2015
PL02.09.2015
SE02.09.2015
GR03.12.2015
Former [2016/09]FI02.09.2015
LT02.09.2015
LV02.09.2015
GR03.12.2015
Former [2016/07]LT02.09.2015
Documents cited:Search[I]US5030621  (BYSTRYN JEAN-CLAUDE [US]);
 [I]US5993829  (BYSTRYN JEAN-CLAUDE [US]);
 [ID]WO2004001004  (UNIV JOHNS HOPKINS MED [US], et al);
 [I]WO2005120558  (UNIV CONNECTICUT HEALTH CT [US], et al);
 [E]EP2116254  (LOKHOV PETR GENRIEVICH [RU]);
International search[A]SU944580  (KIROV NII PERELIVANIYA KROVI [SU]);
 [A]RU2192884  (G UCHREZHDENIE NI, et al);
 [A]US2004009146  (PODHAJCER OSVALDO [AR]);
by applicantEP0009326
 EP0009325
 WO2004001004
 WO2004091383
 US2005142138
 US2006127902
 US2006210975
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.